Can I read Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α on EtoBox?
Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α by Makoto Sasaki; Paul Jordan; Tomas Welbourne; Alireza Minagar; Takashi Joh; Makoto Itoh; John W Elrod; J Steven Alexander is a Medicine article available to read on EtoBox.
What is Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α about?
## Background Cytokine mediated induction of the mucosal addressin cell adhesion molecule-1(MAdCAM-1) expression is associated with the onset and progression of inflammatory bowel disease (__IBD__). ## Results Using western blotting and cell-based ELISA, we show in this study that troglitazone, an activator of the peroxisome proliferator-activated receptor-γ (PPAR-γ), widely used in the treatment of diabetes, has as well recently been highlighted as protective in models of inflammation and cancer. We found that troglitazone (10–40 μM), significantly reduced the TNF-α (1 ng/ml) mediated induction of endothelial MAdCAM-1 in a dose-dependent manner, achieving a 34.7% to 98.4% reduction in induced MAdCAM-1. Trogliazone (20μM) reduced TNF-α induced VCAM-1, ICAM-1 and E-selectin expression. Moreover, troglitazone significantly reduced α4β7-integrin dependent lymphocyte adhesion to TNF-α cultured endothelial cells. ## Conclusions These results suggest that PPAR-γ agonists like troglitazone may be useful in the clinical treatment of IBD.
Who reads Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Makoto Sasaki; Paul Jordan; Tomas Welbourne; Alireza Minagar; Takashi Joh; Makoto Itoh; John W Elrod; J Steven Alexander
- Publisher
- BioMed Central; Springer (Biomed Central Ltd.); London: BioMed Central, 2001-; Springer Science and Business Media LLC (ISSN 1472-6793)
- Published
- 2005
- Language
- EN
- Field
- Medicine (Life Sciences)